Form 8-K - Current report:
SEC Accession No. 0001619856-25-000052
Filing Date
2025-06-23
Accepted
2025-06-23 08:02:21
Documents
12
Period of Report
2025-06-18
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K crbu-20250618.htm   iXBRL 8-K 23700
  Complete submission text file 0001619856-25-000052.txt   145446

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20250618.xsd EX-101.SCH 1791
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20250618_lab.xml EX-101.LAB 23449
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20250618_pre.xml EX-101.PRE 13587
14 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20250618_htm.xml XML 2916
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40631 | Film No.: 251062999
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)